In the latest session, ABVC BioPharma Inc (NASDAQ: ABVC) closed at $1.14 down -3.39% from its previous closing price of $1.18. In other words, the price has decreased by -$0.0400 from its previous closing price. On the day, 3776198 shares were traded.
Ratios:
For a deeper understanding of ABVC BioPharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.28 and its Current Ratio is at 0.28. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABVC now has a Market Capitalization of 11.88M and an Enterprise Value of 14.02M. For the stock, the TTM Price-to-Sale (P/S) ratio is 80.26 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 91.97 whereas that against EBITDA is -1.72.
Stock Price History:
Over the past 52 weeks, ABVC has reached a high of $9.60, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is 1.2559, while the 200-Day Moving Average is calculated to be 1.7098.
Shares Statistics:
For the past three months, ABVC has traded an average of 679.87K shares per day and 747.17k over the past ten days. A total of 10.56M shares are outstanding, with a floating share count of 8.68M. Insiders hold about 17.84% of the company’s shares, while institutions hold 1.05% stake in the company. Shares short for ABVC as of Mar 15, 2024 were 105.84k with a Short Ratio of 1.94, compared to 120.7k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.00% and a Short% of Float of 1.37%.
Earnings Estimates
There are 0 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.06. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for ABVC’s current fiscal year. The highest revenue estimate was $700k, while the lowest revenue estimate was $700k, resulting in an average revenue estimate of $152k. In the same quarter a year ago, actual revenue was $970k, down -84.30% from the average estimate.
